2018

20181030gui

Topics in this issue include:

New - Support for Non-Consecutive Month CSOs

Effective Sunday, November 18 (trade date Monday, November 19), to simplify the submission of trade entry reports, CME ClearPort will support trade entry for Calendar Spread Options (CSOs) on products, typically Agricultural, that do not list consecutive monthly contracts.

This enhancement will be available in New Release for customer testing on Wednesday, November 7.

Back to Top

 

Price Precision Extension

CME Group is implementing end-to-end technology changes to support increased price granularity. Currently, CME Group systems support a maximum of 7 decimals. With this initiative, products with up to 9 decimals may be listed and traded. Effective Sunday, January 13 (trade date Monday, January 14), pending regulatory approval, the 2 Year Treasury Note futures and spreads will move from 7 decimals to 8 to support trading at 1/8 of 1/32.

Customers are encouraged to move to support 9 decimals now; but there are no plans to list a product that uses the 9th decimal at this time.

For more on impacted products and CME Globex, iLink messaging, Drop Copy and Market Data impacts, view the CME Globex Client Impact Assessment.

These enhancements are currently available for testing in New Release.

Back to Top

 




2018

20181031

The CME ClearPort enhancement for non-consecutive Calendar Spread Options (CSOs) has been postponed. The new launch date will be announced in future CME ClearPort Notices.




2018

20181113api

Topics in this issue include:

New - Support for Additional Calendar Spread Options

Effective Sunday, December 2 (trade date Monday, December 3), pending all relevant CFTC regulatory review periods, CME ClearPort will support trade entry for the following Calendar Spread Options (CSOs):

For more information, please refer to SER-8279 in the Special Executive Report (SER) Notice Archive.

This enhancement will be available for customer testing in New Release on Wednesday, November 14.

Back to Top

 

Price Precision Extension

CME Group is implementing end-to-end technology changes to support increased price granularity. Currently, CME Group systems support a maximum of 7 decimals. With this initiative, products with up to 9 decimals may be listed and traded. Effective Sunday, January 13, 2019 (trade date Monday, January 14), pending regulatory approval, the 2 Year Treasury Note futures and spreads will move from 7 decimals to 8 to support trading at 1/8 of 1/32.

Customers are encouraged to move to support 9 decimals now; but there are no plans to list a product that uses the 9th decimal at this time.

The attributes listed below will be impacted.

For more on impacted products and CME Globex, iLink messaging, Drop Copy and Market Data impacts, view the CME Globex Client Impact Assessment.

Trade Capture Reports and Acknowledgements

Price will be impacted at the Trade Capture Report and Trade Instrument Leg Group levels.

Level Field Name FIXML Attribute Name
/TrdCaptRpt - inbound Trade Price LastPx
/TrdCaptRpt/TrdLeg - inbound Leg Last Price LastPx
/TrdCaptRptAck - outbound Trade Price LastPx
/TrdCaptRptAck/TrdLeg - outbound Leg Last Price LastPx
/TrdCaptRpt - outbound Trade Price LastPx
/TrdCaptRpt/TrdLeg - outbound Leg Last Price LastPx

Reference Data

Level Field Name FIXML Attribute Name
/SecDef/Instrmt MinPriceIncrement MinPxIncr
/DerivSecList/DerivSecDef/DerivInstrmt MinPriceIncrement MinPxIncr

These enhancements are currently available for customer testing in New Release.

Back to Top




2018

20181206

Today, CME Group launched CME Reference Data API, a real-time solution for accessing information on every instrument and product at CME Group.

Embed the CME Reference Data API in your system’s product matrices and databases to automate product reference data for all CME Group and hosted partner exchange markets.

CME Reference Data API includes:

  • Contract specifications
  • Product codes and symbols
  • Trade and order type eligibility
  • Instrument lifecycle dates: first and last trade date, notices, delivery and settlement

Key Benefits:

  • Reduce the risk of errors with automated definitions
  • Machine-readable API delivers product and instrument information without human intervention
  • Access CME Group markets and products faster
  • A cost-effective solution to accessing product data

Request Access:

Contact Global Account Management to obtain access to the Reference Data API:

U.S.: +1 312 634 8700
Europe: +44 20 3379 3754
Asia: +65 6593 5505

Additional Resources:




2018

20181219api

Topics in this issue include:

 

CME Reference Data API Launch

CME Group has launched CME Reference Data API, a real-time solution for accessing information on every instrument and product at CME Group.

Embed the CME Reference Data API in your system’s product matrices and databases to automate product reference data for all CME Group and hosted partner exchange markets.

CME Reference Data API includes:

  • Contract specifications
  • Product codes and symbols
  • Trade and order type eligibility
  • Instrument life cycle dates: first and last trade date, notices, delivery and settlement

Key Benefits:

  • Reduce the risk of errors with automated definitions
  • Machine-readable API delivers product and instrument information without human intervention
  • Access CME Group markets and products faster
  • A cost-effective solution to accessing product data

Request Access:

Contact Global Account Management to obtain access to the Reference Data API:

U.S.: +1 312 634 8700
Europe: +44 20 3379 3754
Asia: +65 6593 5505

Additional Resources:

Back to Top

 

Price Precision Extension

CME Group is implementing end-to-end technology changes to support increased price granularity. Currently, CME Group systems support a maximum of 7 decimals. With this initiative, products with up to 9 decimals may be listed and traded. Effective Sunday, January 13, 2019 (trade date Monday, January 14), pending regulatory approval, the 2 Year Treasury Note futures and spreads will move from 7 decimals to 8 to support trading at 1/8 of 1/32.

Customers are encouraged to move to support 9 decimals now; but there are no plans to list a product that uses the 9th decimal at this time.

The attributes listed below will be impacted.

For more on impacted products and CME Globex, iLink messaging, Drop Copy and Market Data impacts, view the CME Globex Client Impact Assessment.

Trade Capture Reports and Acknowledgements

Price will be impacted at the Trade Capture Report and Trade Instrument Leg Group levels.

Level Field Name FIXML Attribute Name
/TrdCaptRpt - inbound Trade Price LastPx
/TrdCaptRpt/TrdLeg - inbound Leg Last Price LastPx
/TrdCaptRptAck - outbound Trade Price LastPx
/TrdCaptRptAck/TrdLeg - outbound Leg Last Price LastPx
/TrdCaptRpt - outbound Trade Price LastPx
/TrdCaptRpt/TrdLeg - outbound Leg Last Price LastPx

Reference Data

Level Field Name FIXML Attribute Name
/SecDef/Instrmt MinPriceIncrement MinPxIncr
/DerivSecList/DerivSecDef/DerivInstrmt MinPriceIncrement MinPxIncr

These enhancements are currently available for customer testing in New Release.

Back to Top




2018

BIZ-Quartalsbericht, März 2018

German translation of the BIS Quarterly Review, March 2018




2018

BIZ-Quartalsbericht März 2018: Volatilität rückt nach Aktienmarktturbulenzen erneut in den Fokus

German translation of the BIS press release about the BIS Quarterly Review, March 2018




2018

BIZ-Quartalsbericht, Juni 2018

German translation of the BIS Quarterly Review, June 2018




2018

Wirtschaftsbericht 2018

German translation of the Annual Economic Report 2018 of the BIS, June 2018 - Die politischen Entscheidungsträger können dem gegenwärtigen Wirtschaftsaufschwung eine nachhaltige Basis verleihen, schreibt die BIZ in ihrem Wirtschaftsbericht. Dazu sollten sie strukturpolitische Maßnahmen ergreifen, mit Blick auf künftige Risiken wieder für größeren Handlungsspielraum in der Geld- und Fiskalpolitik sorgen und die Umsetzung der Regulierungsreformen vorantreiben. ...




2018

BIZ-Quartalsbericht, September 2018

German translation of the BIS Quarterly Review, September 2018




2018

BIZ-Quartalsbericht, Dezember 2018

German translation of the BIS Quarterly Review, December 2018




2018

Director's Update - Feb 2018

OM Director's Update from Lawrence Tong, International Director




2018

Director's Update - Mar 2018

OM Director's Update from Lawrence Tong, International Director




2018

Director's Update - Apr 2018

OM Director's Update from Lawrence Tong, International Director




2018

Director's Update - May 2018

OM Director's Update from Lawrence Tong, International Director




2018

Director's Update - June 2018

OM Director's Update from Lawrence Tong, International Director.




2018

Director's Update - July 2018

OM Director's Update from Lawrence Tong, International Director




2018

Director's Update - Sept 2018

OM Update from Lawrence Tong, International Director




2018

Director's Update - Oct 2018

OM Director's Update from Lawrence Tong, International Director




2018

Director's Update - Nov 2018

OM Director's Update by Lawrence Tong, International DIrector




2018

Director's Update - Dec 2018

OM Director's Update from Lawrence Tong




2018

The 2018 Apple iPad Is More Than $200 Off at Walmart

The sixth-generation 9.7-inch iPad with 128GB of storage and cellular connectivity would normally set you back $559, but is currently marked down to just $349.




2018

2018/19 UEFA Regions' Cup qualifying draw

Europe's top competition for amateur players returns for 2018/19 with 39 nations discovering the fate of their eventual representatives in the preliminary and intermediate round draws.




2018

Women's Champions League Squad of the Season 2018/19

UEFA's technical observers have selected their all-star squad from the 2018/19 UEFA Women's Champions League.




2018

FCCC/SBI/2018/3

Capacity-building work of bodies established under the Convention and its Kyoto Protocol. Compilation and synthesis report by the secretariat.




2018

FCCC/SBSTA/2018/3

Adaptation in human settlements: key findings and way forward. Report by the secretariat.




2018

FCCC/SBI/2018/1

Provisional agenda and annotations. Note by the Executive Secretary.




2018

FCCC/SBSTA/2018/1

Provisional agenda and annotations. Note by the Executive Secretary.




2018

FCCC/SBI/2018/2

Technical workshop on ways to increase the efficiency and transparency of the budget process. Report by the secretariat.




2018

FCCC/APA/2018/1

Agenda and annotations. Note by the Executive Secretary.




2018

FCCC/SBI/2018/3/Add.1

Capacity-building work of bodies established under the Convention and its Kyoto Protocol. Compilation and synthesis report by the secretariat. Addendum. Compilation of capacity-building activities undertaken by bodies established under the Convention and its Kyoto Protocol




2018

FCCC/SBI/2018/4

The 33rd meeting of the Least Developed Countries Expert Group. Report by the secretariat.




2018

FCCC/SBI/2018/5

Implementation of the framework for capacity-building in developing countries. Synthesis report by the secretariat.




2018

FCCC/SBI/2018/7

Arrangements for Intergovernmental Meetings. Note by the Executive Secretary.




2018

FCCC/SBSTA/2018/2

Outcomes of work under the Nairobi work programme on impacts, vulnerability and adaptation to climate change since May 2016. Synthesis report by the secretariat.




2018

FCCC/SBI/2018/INF.5

United Nations Environment Programme response to the independent review of the Climate Technology Centre and Network.




2018

FCCC/SBI/2018/INF.7

Status of submission and review of seventh national communications and third biennial reports. Note by the secretariat.




2018

Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018 [Susceptibility]

Ceftobiprole medocaril is an advanced-generation cephalosporin prodrug that has qualified infectious disease product status granted by the US-FDA and is currently being evaluated in phase 3 clinical trials in patients with acute bacterial skin and skin structure infections (ABSSSIs) and in patients with Staphylococcus aureus bacteremia. In this study, the activity of ceftobiprole and comparators was evaluated against more than 7,300 clinical isolates collected in the United States from 2016 through 2018 from patients with skin and skin structure infections. The major species/pathogen groups were S. aureus (53%), Enterobacterales (23%), Pseudomonas aeruginosa (7%), β-hemolytic streptococci (6%), Enterococcus spp. (4%), and coagulase-negative staphylococci (2%). Ceftobiprole was highly active against S. aureus (MIC50/90, 0.5/1 mg/L; 99.7% susceptible by EUCAST criteria; 42% methicillin-resistant S. aureus [lsqb]MRSA[rsqb]). Ceftobiprole also exhibited potent activity against other Gram-positive cocci. The overall susceptibility of Enterobacterales to ceftobiprole was 84.8% (>99.0% susceptible for isolate subsets that exhibited a non-extended-spectrum β-lactamase [lsqb]ESBL[rsqb]-phenotype). A total of 74.4% of P. aeruginosa, 100% of β-hemolytic streptococci and coagulase-negative staphylococci, and 99.6% of Enterococcus faecalis isolates were inhibited by ceftobiprole at ≤4 mg/L. As expected, ceftobiprole was largely inactive against Enterobacterales that contained ESBL genes and Enterococcus faecium. Overall, ceftobiprole was highly active against most clinical isolates from the major Gram-positive and Gram-negative skin and skin structure pathogen groups collected at U.S. medical centers participating in the SENTRY Antimicrobial Surveillance Program during 2016–2018. The broad-spectrum activity of ceftobiprole, including potent activity against MRSA, supports its further evaluation for the potential ABSSSI indication.




2018

Pediatric Orphan Drug Indications: 2010-2018

BACKGROUND:

Orphan drug development is crucial for children, who are disproportionately affected by rare diseases. Data are lacking on the number, nature, and benefit of recently approved pediatric orphan indications.

METHODS:

We classified the 402 orphan indications the US Food and Drug Administration approved between 2010 and 2018 as "pediatric" if they were approved for children only or targeted pediatric diseases. We determined the number of unique diseases targeted by pediatric orphan indications and calculated the proportion that were for (1) novel drugs, (2) non-novel drugs approved to treat ≥1 common disease, and (3) non-novel drugs approved only to treat rare diseases. Among pediatric orphan indications eligible for US Food and Drug Administration breakthrough designation (granted to drugs potentially representing major therapeutic advances), we calculated the proportion receiving this designation.

RESULTS:

Of the 402 orphan indications, 136 (33.8%) were pediatric. These 136 indications targeted 87 unique diseases; 21 diseases were targeted by ≥1 indication. Of the 136 pediatric orphan indications, 60 (44.1%) were for novel drugs, 45 (33.1%) were for non-novel drugs approved to treat ≥1 common disease, and 31 (22.8%) were for non-novel drugs approved only to treat rare diseases. Among 97 indications eligible for breakthrough designation, 20 (20.6%) received this designation.

CONCLUSIONS:

Recent orphan drug development has increased the availability of treatments for pediatric rare diseases. Most pediatric orphan indications expanded use of existing drugs, and many targeted the same disease. Some indications may represent breakthroughs, but substantial unmet need for treatments remains for most pediatric rare diseases.




2018

Volkswagen gives UEFA Futsal EURO 2018 wheels

The 55-vehicle Volkswagen fleet which will transport players and officials at UEFA Futsal EURO 2018 has been handed over to the tournament organisers.




2018

UEFA Futsal EURO 2018 finals draw made

Hosts Slovenia have been handed a tough group with Italy and Serbia while France's debut finals match will be against holders Spain after the draw was made in Ljubljana.




2018

UEFA Futsal EURO 2018: meet the teams

We look at the 12 teams that will compete in Slovenia between 30 January and 10 February – from champions Spain and former winners Italy and Russia to debutants France.




2018

Futsal EURO 2018: all you need to know

UEFA Futsal EURO 2018 runs until 10 February in Ljubljana with 12 teams aiming for the title: we give you the key pointers to following a tournament full of skill and passion.




2018

Where to watch UEFA Futsal EURO 2018

You can watch UEFA Futsal EURO 2018 across Europe and the world thanks to UEFA's broadcast partners and the live streaming of games on UEFA.com and our YouTube channel UEFA.tv.




2018

UEFA Futsal EURO 2018 results, highlights

See all the results and highlights from UEFA Futsal EURO 2018 at Ljubljana's Stožice Arena.




2018

Futsal EURO 2018 team of the tournament

Ricardinho, Taynan, Douglas Junior, Pola and Georgi Zamtaradze have been named the best five players of the 2018 finals and are also in the 14-strong selection for the Team of the Tournament.




2018

2018/19 U19 EURO qualifying round draw made

The 2018/19 UEFA European Under-19 Championship qualifying round draw has been made in Nyon, starting the road to the July 2019 finals in Armenia.




2018

Amazon Kindle Paperwhite (2018)

The waterproof Kindle Paperwhite offers more for your money than any other ebook reader on the market.




2018

Tallinn to stage 2018 UEFA Super Cup

The 2018 UEFA Super Cup will be played on 15 August of next year at Tallinn's Lilleküla Stadium, the first senior UEFA final in Estonia in the centenary of that republic's creation.




2018

All you need to know about the 2018 UEFA Super Cup

Real Madrid will take on Atlético in Tallinn, Estonia, on Wednesday.